You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/29/20 | DEF 14A | Definitive proxy statements |
|
41 | |
| 04/28/20 | 8-K | Current report filing |
|
3 | |
| 04/21/20 | 8-K | Current report filing |
|
3 | |
| 04/13/20 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
8 | |
| 04/03/20 | 8-K | Current report filing |
|
3 | |
| 03/23/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/20/20 | 8-K | Current report filing |
|
5 | |
| 03/13/20 | 8-K | Current report filing |
|
10 | |
| 03/13/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
116 |
| 03/09/20 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 |
